Tat (48-56) + PPF-BBI [5-15]

General Information


DRACP ID  DRACP03861

Peptide Name   Tat (48-56) + PPF-BBI [5-15]

Sequence  RKKRRQRRRCWTKSIPPKPC

Sequence Length  20

UniProt ID  C3RSZ6 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C110H194N44O24S2

Absent amino acids  ADEFGHLMNVY

Common amino acids  R

Mass  292020

Pl  12.52

Basic residues  10

Acidic residues  0

Hydrophobic residues  2

Net charge  10

Boman Index  -11342

Hydrophobicity  -219

Aliphatic Index  19.5

Half Life 
  Mammalian: 4.4 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  5625

Absorbance 280nm  296.05

Polar residues  4

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 31337113

Title  Discovery and Rational Design of a Novel Bowman-Birk Related Protease Inhibitor

Doi Not available

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  13836

DRACP is developed by Dr.Zheng's team.